IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Defilade Capital Management, L.P.

Portfolio Profile

CIK: 0002088557 | EMERYVILLE, CA

Investment Profile

Style

GARP

Turnover

Very High

Orientation

Concentrated trader
$746.9M
AUM
39
Positions
46.51%
Top 10 Conc.
83.08%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1ELI Lilly & Co(LLY)39,086$46.9M6.28%
2Pfizer Inc(PFE)1,771,743$42.7M5.71%
3Veeva SYS Inc(VEEV)236,709$42.0M5.62%
4Biomarin Pharmaceutical Inc(BMRN)682,005$39.0M5.22%
5PTC Therapeutics Inc(PTCT)433,699$35.4M4.74%
6

Sector Allocation

Latest filing, equity positions only

Healthcare95.64% · $714.4M
Unclassified4.36% · $32.6M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare100%95.64%-4.36%
Unclassified0%4.36%+4.36%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$737.7M | 33 pos.
$712.2M | 31 pos.
$746.9M | 39 pos.
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

20
New
12
Baxter Intl Inc(BAX)
1,459,380
$31.1M
4.17%
7Insmed Inc(INSM)281,838$30.0M4.02%
8Zimmer Biomet Holdings Inc(ZBH)317,426$27.3M3.66%
9Insulet Corp(PODD)176,932$26.9M3.61%
10Thermo Fisher Scientific Inc(TMO)51,934$26.0M3.49%
Cap SizePrev %Curr %Change
Large Cap54.28%47.86%-6.42%
Mid Cap30.5%25.54%-4.96%
Small Cap10.66%13.37%+2.71%
Mega Cap2.67%6.28%+3.61%
Unclassified0%4.36%+4.36%
Micro Cap1.89%2.6%+0.71%
Closed
8
Increased
10
Decreased
1
Unchanged